Sukhtian Ghiath M. · Outlook Therapeutics, Inc. · 2h agono track record yet
Long 2,525,252 shares of OTLK
Bought 2,525,252 @ $0.99 avg · $2,499,999 · 2026-08-12
Form 4: Sukhtian Ghiath M. bought OTLK
Sukhtian Ghiath M. (Director at Outlook Therapeutics, Inc.) reported an open-market purchase of 2,525,252 shares of OTLK at an average $0.99, roughly $2,499,999, in a Form 4 filed 2026-08-14.